WCN26-6543 DEFINING THE ROLES OF SGLT2IS AND GLP-1 RAS IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES AND OVERWEIGHT/OBESITY: A DELPHI CONSENSUS